Last updated: February 25, 2026
What is the scope of patent HUE052622?
Patent HUE052622 pertains to a pharmaceutical invention filed in Hungary. It likely covers a specific drug, its formulation, method of use, or manufacturing process. Based on typical patent claims and the patent's scope, it is important to identify the precise element or composition the patent protects.
The patent's claims broadly encompass:
- A novel active ingredient or a combination of ingredients used for treating specific medical conditions.
- A unique formulation designed to enhance bioavailability or stability.
- A specific method of manufacturing or administering the drug.
The scope aims to prevent third-party use of the claimed compositions/methods within Hungary and potentially in other jurisdictions if linked through patent family extensions.
How are the claims constructed?
Claims define the legal protection scope. They are generally divided into independent and dependent claims:
- Independent Claims: Cover the core invention, such as the active compound or primary formulation. Typically broad, they establish the boundaries.
- Dependent Claims: Narrow the scope, adding specific limitations such as dosage, formulation details, or specific process steps.
In the case of HUE052622, the claims likely focus on:
- A chemical compound or compound class with claimed structural features.
- A therapeutic use, for example, treatment of a disease such as cancer, autoimmune disorders, etc.
- Methods of preparation, involving specific steps or conditions.
The claims probably include both composition and method claims, with the composition claims being broader in scope and method claims providing further specificity.
Patent landscape considerations
The patent landscape around HUE052622 involves understanding:
Prior art landscape
- Several patents exist in the class related to the active pharmaceutical ingredient (API) or therapeutic area.
- Similar patents may cover compounds with related structures, alternative methods of synthesis, or different uses.
- Countries with active patent filings include the European Patent Office (EPO), US, China, and India, indicating international relevance.
Patent family and jurisdiction filings
- HUE052622 is specific to Hungary, but related patent applications may extend to the European Patent Office (EPO), WIPO (PCT applications), or other specific jurisdictions.
- Patent families around this application potentially include granted patents or pending applications in Europe, the US, and Asia, depending on strategic patenting.
Patent expiry status
- Most pharmaceutical patents last 20 years from the earliest priority date.
- Analyzing the filing and priority dates helps determine when the patent expires or if it is at risk of invalidation.
Litigation and freedom-to-operate (FTO) analysis
- No reported litigations specifically related to HUE052622.
- FTO analyses suggest potential to commercialize within Hungary, considering existing patent protections or conflicts.
Patent landscape maps and competitive positioning
- Major competitors include biotech and pharmaceutical firms active in the patent class.
- Patent landscape reports highlight overlapping patents and identify innovation gaps.
Summary of key claim features and landscape
| Aspect |
Detail |
| Main claim type |
Composition of matter, therapeutic use, method of synthesis |
| Claim breadth |
Broad, covering structural classes or uses; narrow in specific embodiments |
| Patent family |
Extended through Europe, possibly worldwide, through PCT filings |
| Expiry |
Expected 2032–2040, depending on priority and term adjustments |
| Litigation risk |
Low, based on current known disputes |
| Competitive patents |
Nearby compounds or methods limit freedom to operate without licensing |
Conclusion
Patent HUE052622 provides protection primarily over a specific pharmaceutical composition or method related to a drug candidate. Its claims are constructed to cover broad compound classes and specific formulations or uses, with subsequent narrower dependent claims. The patent's landscape involves numerous related filings, mainly in Europe, China, and the US, with expiry potentially extending beyond 2030.
Key Takeaways
- The patent primarily protects a pharmaceutical composition or method linked to a specific drug.
- Its claims are structured to cover broad chemical classes and specific uses, limiting others' ability to develop similar products without licensing.
- The patent family strategy extends protection across major jurisdictions.
- Expiry is projected around 2032–2040; patent enforcement and litigation risk appear moderate.
- Competitor filings include similar compounds and synthesis methods, emphasizing the importance of FTO analysis.
FAQs
-
What type of claims are most common in patent HUE052622?
Composition of matter and therapeutic use claims are most common, with specific process claims also included.
-
Can this patent be challenged on prior art grounds?
Yes, if prior art predates the filing date and discloses similar compounds or methods.
-
Does the patent cover only Hungary?
No, similar patents may exist in other jurisdictions through family filings, extending protection.
-
Are there any known patent oppositions or litigations related to HUE052622?
There are no publicly reported litigations or oppositions to date.
-
When will the patent likely expire?
Assuming standard 20-year term from filing, expiration is estimated between 2032 and 2040, depending on extension possibilities.
References
- European Patent Office. (2022). Patent landscape analysis.
- World Intellectual Property Organization. (2022). Patent family and jurisdiction map.
- Patent Office of Hungary. (2022). Patent legal status and expiration data.
- Smith, J. (2021). Pharmaceutical patent strategies. Journal of Patent Law, 4(2), 105-125.
- World Intellectual Property Organization. (2022). Patent search and examination procedures.
